Our study adds to the literature by providing evidence for the appropriate down-regulation of another p53-regulated gene, PLAC1, as well as demonstrating the effect in ovarian cancer cells, which were not included in the Madan et al. study [42]. The gene discussed is TP53; the disease is ovarian carcinoma.